Early Onset Colorectal Cancer Detection
Part of paid clinical trials in Duarte, California.
- Sponsor
- City of Hope Medical Center
- Study ID
- NCT06342401
- Status
- Recruiting
Conditions
- Colorectal Adenocarcinoma
- Colorectal Cancer
- Colorectal Cancer Stage I
- Colorectal Cancer Stage II
- Colorectal Cancer Stage III
- Colorectal Cancer Stage IV
- Colorectal Neoplasms
- Colorectal Neoplasms Malignant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Accepted
Interventions
- ENCODE — DIAGNOSTIC_TESTA panel of microRNA, both cell-free and exosomes, whose expression level is tested from plasma samples from patients with early onset colorectal cancer and non-disease controls.
Study Details
Colorectal cancer (CRC) once predominantly affected older individuals, but in recent years has witnessed a progressive increase in incidence among young adults. Once rare, early-onset colorectal cancer (EOCRC, that is, a CRC diagnosed before the age of 50) now constitutes 10-15% of all newly diagnosed CRC cases and it stands as the first cause of cancer-related death in young men and the second for young women. This study aims to detect EOCRC with a non-invasive test, using a blood-based molecular assay based on microRNA (ribonucleic acid)
Key Dates
- Start date
- Apr 15, 2023
- Status verified
- Jan 2026
- Primary completion
- Jun 18, 2026
- Completion
- Jun 18, 2026
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: Early onset colorectal cancer (Training cohort)Colorectal cancer diagnosed before the age of 50
- Arm: Non-disease controls (Training cohort)Individuals free from colorectal cancer, younger than 50 years of age
- Arm: Early onset colorectal cancer (Validation cohort)Colorectal cancer diagnosed before the age of 50
- Arm: Non-disease controls (Validation cohort)Individuals free from colorectal cancer, younger than 50 years of age
Primary Outcome Measure
Sensitivity [ Time Frame: Through study completion, an average of 1 year ]
Central Contacts
- Ajay Goel, PhD626-218-3452
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| City of Hope Medical Center | Duarte | California | 91010 | Alessandro Mannucci, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Duarte, CA
By condition
By specialty
By research site
Related Studies
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal CancerPHASE3 · Recruiting · Surgimab · Duarte, California
- Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including SarcomasPHASE1 · Recruiting · Inhibrx Biosciences, Inc · Scottsdale, Arizona